Nyse bdx.

Becton, Dickinson and Company (NYSE:BDX) is a New Jersey-based multinational medical device company. On January 24, the company announced a quarterly dividend of $0.91 per share, which was ...Becton, Dickinson and Company (NYSE:BDX) is a global medical technology company that specializes in the development, manufacturing, and distribution of a wide range of medical devices, laboratory ...D.A. Davidson & CO. lifted its stake in shares of Becton, Dickinson and Company ( NYSE:BDX – Free Report) by 2.0% during the second quarter, according to its most recent filing with the ...FRANKLIN LAKES, NJ (November 9, 2023) - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fourth quarter and full year of fiscal 2023, which ended September 30, 2023. “We achieved another quarter, and another year, of strong performance through our …

FRANKLIN LAKES, N.J., Sept. 23, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has submitted a pre-market ...Jun 20, 2023 · Divestiture Advances BD2025 Strategy to Simplify Portfolio and Focus on Higher-Growth Markets. FRANKLIN LAKES, N.J., June 20, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has signed a definitive agreement to sell its Surgical Instrumentation platform to STERIS (NYSE: STE) for $540 million.

Polar Capital Holdings Plc bought a new stake in Becton, Dickinson and Company (NYSE:BDX - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 134,996 shares of the medical instruments supplier's stock, valued at apprNov 30, 2023 · About BDX. Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.

Nov 29, 2023 · Becton, Dickinson and Company (BDX) is currently at $267.48, up $1.68 or 0.63% --Would be highest close since Sept. 5, 2023, when it closed at $272.88 --Currently up six consecutive days; up 3.77% ... Jun 1, 2023 · FRANKLIN LAKES, N.J. (June 1, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that Laura Boros has been named president of Pharmaceutical Systems (PS), effective today. Boros will be responsible for driving global strategic, operational and commercial performance of the PS ... On Friday, Becton Dickinson and Co (BDX:NYQ) closed at 238.89, 4.49% above its 52-week low of 228.62, set on Mar 13, 2023. Data delayed at least 15 minutes, as of Nov 24 2023 18:10 GMT. Latest Becton Dickinson and Co (BDX:NYQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.Jun 20, 2023 · Divestiture Advances BD2025 Strategy to Simplify Portfolio and Focus on Higher-Growth Markets. FRANKLIN LAKES, N.J., June 20, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has signed a definitive agreement to sell its Surgical Instrumentation platform to STERIS (NYSE: STE) for $540 million.

Don’t let the currency conversion trip you up. Convert Becton Dickinson and Company stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock. Select a currency. USD. NYSE: Becton Dickinson and Company ( BDX) = 256.11 USD. Provided by Alpha Vantage.

Becton Dickinson (NYSE:BDX) provides the medical equipment and supplies that underpin our healthcare system. The necessity of those products means that Becton Dickinson enjoys relatively inelastic ...

The average twelve-month price prediction for Becton, Dickinson and Company is $283.86 with a high price target of $310.00 and a low price target of $260.00. Learn more on BDX's analyst rating history. Do Wall Street analysts like Becton, Dickinson and Company more than its competitors?FRANKLIN LAKES, N.J., July 28, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced today it has acquired MedKeeper, a ...The FDA determined that another recall of BD (NYSE:BDX) Alaris infusion pumps is Class I, the most serious kind. In the latest Alaris recall, the company cites compatibility issues with Cardinal Health Monoject syringes. The issue mainly relates to changes made to the products by Cardinal Health. It affects more than 1 million total …Nov 29, 2023 · Becton, Dickinson and Company (NYSE:BDX) pays an annual dividend of $3.64 per share and currently has a dividend yield of 1.52%. The company has been increasing its dividend for 51 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 73.39%. 16 Sep, 2016, 06:59 ET. FRANKLIN LAKES, N.J., Sept. 16, 2016 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) and Vancive Medical Technologies™, an Avery Dennison (NYSE: AVY ...Price. %Change. BDX. 238.89. +0.88%. You can practice and explore trading BDX stock methods without spending real money on the virtual paper trading platform. Webull offers BDX Ent Holdg (BDX) historical stock prices, in-depth market analysis, NYSE: BDX real-time stock quote data, in-depth charts, free BDX options chain data, and a fully built ...

Get the latest Becton Dickinson and Co (BDX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …Becton, Dickinson and Company last posted its earnings results on November 9th, 2023. The medical instruments supplier reported $3.42 earnings per share for the …FRANKLIN LAKES, N.J., Nov. 21, 2023 / PRNewswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Ronald (Ron) Silverman, MD, FACS, has been named executive vice president and chief medical officer of BD, effective Dec. 4, 2023. Dr. Silverman will be …Download Historical Stock Quotes for Becton Dickinson and Company [NYSE,BDX] in a range of formats.Polar Capital Holdings Plc bought a new stake in Becton, Dickinson and Company (NYSE:BDX - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission.The fund bought 134,996 shares of the medical instruments supplier's stock, valued at approximately $35,640,000.FRANKLIN LAKES, N.J. (June 1, 2023) - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that Laura Boros has been named president of Pharmaceutical Systems (PS), effective today. Boros will be responsible for driving global strategic, operational and commercial …WALTHAM, Mass., Oct. 25, 2018 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today completed its previously announced acquisition of the Advanced Bioprocessing business from BD (Becton, Dickinson and Company – NYSE: BDX), a leading global medical technology company, for $477 …

Becton, Dickinson and Company (NYSE:BDX) is a New Jersey-based medical technology company that mainly specializes in the production of medical devices. In May, Barclays raised its price target on ...Dec 2, 2021 · FRANKLIN LAKES, N.J., Dec. 2, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced today it has acquired Venclose, Inc., a ...

12. Becton, Dickinson and Company (NYSE:BDX) Dividend Yield as of February 14: 1.50%. Number of Hedge Fund Holders: 52 Becton, Dickinson and Company (NYSE:BDX), also known simply as BD, is an ...The FDA determined that another recall of BD (NYSE:BDX) Alaris infusion pumps is Class I, the most serious kind. In the latest Alaris recall, the company cites compatibility issues with Cardinal Health Monoject syringes. The issue mainly relates to changes made to the products by Cardinal Health. It affects more than 1 million total …Nov 2, 2023 · The top 21 shareholders own 51% of the company. Insiders have been selling lately. A look at the shareholders of Becton, Dickinson and Company ( NYSE:BDX) can tell us which group is most powerful ... Friday, the FDA said that Becton, Dickinson, And Company BDX is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health Inc's CAH Monoject syringes. The FDA has ...Becton, Dickinson and Company (NYSE:BDX) is a New Jersey-based medical technology company that mainly specializes in the production of medical devices. In May, Barclays raised its price target on ...Polar Capital Holdings Plc purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) in the second quarter, Holdings Channel.com reports.The institutional ...Becton, Dickinson and Company (BDX) NYSE - Nasdaq Real Time Price. Currency in USD. Follow. 2W 10W 9M. 238.26 +2.08 (+0.88%) At close: 03:59PM EST.

BDX U.S.: NYSE Becton Dickinson & Co. Watch list NEW Set a price target alert After Hours Last Updated: Dec 1, 2023 4:23 p.m. EST Delayed quote $ 238.25 0.00 0.00% …

Nov 13, 2023 · Read more on BDX stock here. Becton, Dickinson, and Company is a healthcare company with strong fundamentals and a history of dividend growth. ... (NYSE:BDX), which is part of the healthcare ...

Medical technology company Becton, Dickinson & Co (NYSE: BDX) saw shares plummet recently on weaker-than-expected guidance. The company expects revenues of between $20.1 billion and $20.3 billion ...Becton, Dickinson and Company. Trade name. BD. Type, Public · Traded as · NYSE: BDX · S&P 500 component. Industry, Medical equipment, Consulting. Founded, East ...Read more on BDX stock here. Becton, Dickinson, and Company is a healthcare company with strong fundamentals and a history of dividend growth. ... (NYSE:BDX), which is part of the healthcare ...Expands Access to BD HPV Test that More Precisely Identifies Patients' Risk for Cervical Cancer. FRANKLIN LAKES, N.J., Feb. 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: …Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.FRANKLIN LAKES, N.J., Dec. 4, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it will present the next ...The average twelve-month price prediction for Becton, Dickinson and Company is $283.86 with a high price target of $310.00 and a low price target of $260.00. Learn more on BDX's analyst rating history. Do Wall Street analysts like Becton, Dickinson and Company more than its competitors?April 16, 2021 By Sean Whooley. The FDA has identified another recall for the Alaris infusion pump from BD (NYSE:BDX) as Class I, the most serious kind of recall. BD’s latest recall, initiated on March 3, 2021, involves its BD Alaris infusion pump module system, which includes an infusion pump and vital signs monitoring system with a PC unit ...Becton, Dickinson and Company ( NYSE: BDX) is a $75-billion market cap global healthcare company that specializes in developing, manufacturing, and selling a wide range of medical supplies ...BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the U.S. Food and Drug Administration (FDA) Safety...To get a copy of GED, a person needs to download and complete Attachment H, which is the New York State High School Equivalency Diploma or Transcript; pay a fee via money order or certified check; and submit the document to the New York Sta...Nov 30, 2023 · Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.

Is BDX stock a buy or sell? The best stock pickers were taking a bullish view. The number of bullish hedge fund positions advanced by 3 lately. Becton, Dickinson and Company (NYSE: BDX) was in 65 ...FRANKLIN LAKES, N.J., Jan. 5, 2023 / PRNewswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its first quarter of fiscal year 2023 on Thursday, February 2, 2023./PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it will report its fiscal 2023... BDX : …Friday, the FDA said that Becton, Dickinson, And Company NYSE:BDX is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health Inc's …Instagram:https://instagram. tradeezhealth insurance companies marylanddental insurance plans in arizonacan you get a mortgage without tax returns FRANKLIN LAKES, N.J., Dec. 9, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced publication of the results from a ... ssbankcheapest nasdaq stock 12. Becton, Dickinson and Company (NYSE:BDX) Dividend Yield as of February 14: 1.50%. Number of Hedge Fund Holders: 52 Becton, Dickinson and Company (NYSE:BDX), also known simply as BD, is an ... fidelity cryptocurrency trading 16 Sep, 2016, 06:59 ET. FRANKLIN LAKES, N.J., Sept. 16, 2016 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) and Vancive Medical Technologies™, an Avery Dennison (NYSE: AVY ...GAAP and adjusted diluted EPS from continuing operations were $0.53 and $3.42, respectively. For the full fiscal year 2023, BDX's revenue reached $19.4 billion, marking a 2.7% increase as reported ...Becton, Dickinson ( NYSE: BDX) will sell its surgical instrumentation platform to STERIS ( NYSE: STE) for $540M. BD ( BDX) said the move supports its strategy of simplifying its product portfolio ...